| Literature DB >> 29088056 |
Lauriane Salinas1, Ankita Chaudhary1, Jacopo Guidotti1, André Mermoud1, Kaweh Mansouri1,2.
Abstract
Minimally invasive glaucoma surgery includes different devices which provide a less invasive and safer means of reducing intraocular pressure. The XEN Gel Stent (Allergan Inc., CA) is an ab interno procedure which creates a subconjunctival drainage pathway. It is a new surgical device and there is a paucity of data on complications and their management. We report a clinical case of a leaking bleb after XEN surgery managed by bleb revision, conjunctival suturing, and XEN replacement.Entities:
Mesh:
Year: 2018 PMID: 29088056 DOI: 10.1097/IJG.0000000000000811
Source DB: PubMed Journal: J Glaucoma ISSN: 1057-0829 Impact factor: 2.503